interleukin-8 and Depressive-Disorder--Treatment-Resistant

interleukin-8 has been researched along with Depressive-Disorder--Treatment-Resistant* in 1 studies

Other Studies

1 other study(ies) available for interleukin-8 and Depressive-Disorder--Treatment-Resistant

ArticleYear
Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression.
    Journal of psychiatric research, 2021, Volume: 140

    In cross-sectional studies of depressed patients, relationships between depression and levels of IL-8 are inconsistent, and have not been examined in relation to sex. Given identified sex differences in longitudinal data, it is important to evaluate sex-specific cross-sectional relationships between IL-8 and depressive symptoms, which may explain some inconsistency in the extant literature. It is further unknown whether IL-8 levels may relate to specific symptom profiles among depressed patients, with or without regard to sex.. Among 108 patients with treatment resistant depression (50 females), we evaluated cross-sectional relationships between IL-8 and depression severity, as measured by the Hamilton Depression Rating Scale [HAM-D] Score, and examined sex-specific relationships, as well as relationships with depressive symptom profiles. Other inflammatory markers (IL-6, IL-10, TNF-α, CRP) were also explored in relation to HAM-D.. IL-8 may be related to anxiety symptoms across sexes, but may have a sex-specific relationship with other depressive symptoms. Further evaluation of sex-specific relationships between IL-8, depression symptom profiles, treatment response, and potential neurobiological correlates, may inform mechanisms of depression pathophysiology and aid in development of precision medicine strategies.

    Topics: Anxiety Disorders; Cross-Sectional Studies; Depression; Depressive Disorder, Treatment-Resistant; Female; Humans; Interleukin-8; Male

2021